Lorenz Mayr

Chief Executive Officer (CEO)
Vector BioPharma AG

Dr. Mayr is the CEO of Vector BioPharma. Prior to Vector BioPharma, Dr. Mayr has been the Chief Technology Officer for GE Healthcare Life Sciences and was responsible for all R&D investments, research programmes, business growth strategy, technology innovation, and R&D talent development across all business areas (BioProcess, Imaging Diagnostics/Contrast Media, Research Tools and Applied Markets, Cell & Gene Therapy, New Opportunities). Previously, he has been working as Vice President & Global Head, Reagents & Assay Development with responsibility for generation of all biological reagents and assay development activities across all therapeutic research areas at AstraZeneca.